2026 Annual Meeting | C126 - Essentials of Diagnosis and Management of Hemorrhagic Stroke

Date Tuesday 04/21/26

Time 07:00 AM - 09:00 AM CDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Claude Hemphill III, MD, FAAN

Topic(s) Cerebrovascular Disease and Interventional Neurology

Learning Objectives Participants should be able to develop an acute intracerebral hemorrhage management pathway at their hospital that focuses on early intervention regarding blood pressure, coagulopathy reversal, the role of surgery, and other relevant aspects. Participants should also develop skills in judicious prognostic assessment and understand pitfalls related to diagnostic uncertainty.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
07:00 AM - 07:05 AM CDT	Introduction	Intracerebral Hemorrhage – Focus on Intervention Claude Hemphill III, MD, FAAN
07:05 AM - 07:30 AM CDT	Speaker	Emergency Blood Pressure Management for ICH - Current and Future Adam De Havenon, MD, FAAN
07:30 AM - 07:55 AM CDT	Speaker	Who Needs Surgical Intervention for Intracerebral Hemorrhage? Wendy C. Ziai, MD
07:55 AM - 08:20 AM CDT	Speaker	Bundles of Care for Intracerebral Hemorrhage - Acute Care and Recovery Claude Hemphill III, MD, FAAN
08:20 AM - 08:50 AM CDT	Discussion	Case-based Discussions of Prognostic Decision-making Claude Hemphill III, MD, FAAN, Wendy C. Ziai, MD, Adam De Havenon, MD, FAAN
08:50 AM - 09:00 AM CDT	Q&A	Questions and Answers Claude Hemphill III, MD, FAAN, Wendy C. Ziai, MD, Adam De Havenon, MD, FAAN

Faculty Disclosures
Claude Hemphill III, MD, FAAN	Dr. Hemphill has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Hemphill has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Aurenar. Dr. Hemphill has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various legal firms. The institution of Dr. Hemphill has received research support from NIH/NINDS.
Wendy C. Ziai, MD	Dr. Ziai has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Ziai has received research support from NIH. Dr. Ziai has received publishing royalties from a publication relating to health care. Dr. Ziai has received personal compensation in the range of $500-$4,999 for serving as a Consultant with DOJ.
Adam De Havenon, MD, FAAN	Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has stock in Certus. Dr. De Havenon has stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.

��ɫ��

��ɫ��